Dr. Young is assistant clinical professor of medicine at the University of Colorado and consultant physician at Denver Infectious Disease Consultants. He has been recently appointed as Head of Medical Affairs for Health Connections International, a Dutch non-governmental organization dedicated to strengthening health care systems targeting the HIV, tuberculosis and drug use epidemics in resource-poor settings and developing countries of Central Asia.

The much-traveled Dr. Young is a long-term resident of Colorado's Rocky Mountains, but was raised in New York and San Diego. Dr. Young began his graduate studies at the University of Colorado in Boulder, where he received a Ph.D. in molecular biology and biochemistry working in the laboratory of Nobel laureate Thomas Cech. He went on to earn his medical doctorate in 1992 from the University of Colorado School of Medicine and completed his post-graduate training in internal medicine and infectious diseases at the University of Colorado and now co-directs the course on HIV primary care for medical house staff.

Dr. Young is the author of numerous journal articles, reviews and studies relating to HIV and its treatment. He is a principal investigator with the HIV Outpatient Study, a massive ongoing analysis of the health of HIV-positive people throughout the U.S. A member of the HIV Medicine Association and the American Academy of HIV Medicine, Dr. Young is also actively involved in educating health care professionals and community groups throughout the world on HIV-related subjects. He has devoted the past five years to training HIV physicians in Eastern Europe and Central Asia.

Disclosures

Dr. Young has received consulting fees from Bristol-Myers Squibb Company, Cerner Corporation, Gilead Sciences, GlaxoSmithKline, Hoffman-LaRoche, Merck & Co., Monogram Bioscience, Pfizer, Tibotec and Vertex. He has served on speakers bureaus for GlaxoSmithKline, Merck & Co., Monogram Biosciences and Tibotec. In addition, he has received grant/research funding from Bristol-Myers Squibb Company, Cerner Corporation, Gilead Sciences, GlaxoSmithKline, Hoffman-LaRoche and Merck & Co.